search

Active clinical trials for "Aortic Valve Stenosis"

Results 91-100 of 802

PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate

Symptomatic Severe Aortic Stenosis

The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN 3 transcatheter heart valve and delivery systems which are intended for use in patients with symptomatic, calcific, and severe aortic stenosis, and those with intermediate risk.

Active11 enrollment criteria

Portico NG Approval Study

Symptomatic Severe Aortic Stenosis

The purpose of this clinical study is to evaluate the acute safety and effectiveness of the next-generation Navitor (Portico™ NG) Transcatheter Aortic Heart Valve as assessed by the rate of all-cause mortality at 30 days and the rate of moderate or greater paravalvular leak at 30 days in a high or extreme surgical risk patient population to support CE (Conformité Européenne) Mark and FDA approval.

Active14 enrollment criteria

Early Feasibility Study for the Foldax Tria Aortic Heart Valve

Aortic Valve DiseaseAortic Valve Stenosis

The purpose of this study is to conduct the initial clinical investigation of the Foldax Polymer Aortic Valve to collect evidence on the device's safety and performance. The study is anticipated to confirm successful clinical safety and clinical effectiveness with significant improvements in clinical hemodynamic performance.

Active28 enrollment criteria

PERCEVAL S Valve Clinical Study for Chinese Registration

Aortic Valve DiseaseAortic Valve Stenosis

This is a prospective, open, single arm, multi-center clinical study in China. The primary objective of this study is to demonstrate the safety and effectiveness of the PERCEVAL S heart valve when used to replace a diseased native or malfunctioning prosthetic aortic valve in the indicated Chinese population for tissue heart valve replacement and suitable to the PERCEVAL S valve. The secondary objectives are to collect all relevant device and subject demographics, procedural and hospital discharge, short and long-term data, as described in the secondary endpoints section.

Active18 enrollment criteria

China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the Chinese Population...

Aortic StenosisSymptomatic Aortic Stenosis1 more

To evaluate the safety and effectiveness of the SAPIEN 3 (Edwards Lifesciences, Irvine, California) transcatheter heart valve implantation (TAVI) in Chinese patients with symptomatic severe calcific aortic stenosis who are considered at high risk for surgical valve replacement.

Active10 enrollment criteria

Evolut PRO China Clinical Study

SevereSymptomatic Aortic Stenosis

Interventional study to evaluate the safety and efficacy of the Medtronic CoreValve™ Evolut™ PRO System when used by China implanting centers in Chinese patients with severe symptomatic aortic stenosis (AS) who are at high risk for Surgical Aortic Valve Replacement (SAVR).

Active7 enrollment criteria

Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart...

Aortic Valve Stenosis

The objective of this study is to determine the safety and efficacy of transcatheter aortic valve replacement (TAVR) via a transfemoral approach in HF patients with moderate AS as compared with OHFT.

Active43 enrollment criteria

PERIGON Japan Trial

Aortic Stenosis

The purpose of this study is to evaluate the safety and effectiveness of the 17mm MDT-2215 aortic valve bioprosthesis.

Active40 enrollment criteria

PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk

Symptomatic Severe Aortic Stenosis

The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN XT transcatheter heart valve and delivery systems which are intended for use in patients with symptomatic, calcific, severe aortic stenosis.

Active12 enrollment criteria

PERIGON Pivotal Trial

Aortic Stenosis

To evaluate the safety and effectiveness of the Model 400 aortic valve bioprosthesis.

Active31 enrollment criteria
1...91011...81

Need Help? Contact our team!


We'll reach out to this number within 24 hrs